XML 75 R64.htm IDEA: XBRL DOCUMENT v3.20.2
Segment Reporting (Details) - USD ($)
3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Jun. 30, 2020
Consolidated revenue $ 13,520,246 $ 1,439,826  
Consolidated net loss (4,305,931) (4,929,030)  
Total assets 141,270,659   $ 152,836,330
Aytu BioScience      
Consolidated revenue 5,752,000 1,440,000  
Consolidated net loss (2,950,000) (4,929,000)  
Total assets 116,499   126,267,000
Aytu Consumer Health      
Consolidated revenue 7,768,000 0  
Consolidated net loss (1,356,000) $ 0  
Total assets $ 24,772,000   $ 26,569,000